MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
47 hedge funds and large institutions have $29.9M invested in Merrimack Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 37 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
84% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 37
Holders
47
Holding in Top 10
1
Calls
$214K
Puts
$114K
Top Buyers
| 1 | +$1.03M | |
| 2 | +$308K | |
| 3 | +$220K | |
| 4 |
CCIA
Campbell & Co Investment Adviser
Baltimore,
Maryland
|
+$111K |
| 5 |
Morgan Stanley
New York
|
+$108K |
Top Sellers
| 1 | -$2.87M | |
| 2 | -$1.65M | |
| 3 | -$1.51M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$889K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$409K |